| 0.978 0.061 (6.65%) | 10-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.24 |
1-year : | 1.45 |
| Resists | First : | 1.07 |
Second : | 1.24 |
| Pivot price | 0.9 |
|||
| Supports | First : | 0.89 |
Second : | 0.79 |
| MAs | MA(5) : | 0.97 |
MA(20) : | 0.88 |
| MA(100) : | 0.75 |
MA(250) : | 0.73 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 58.6 |
D(3) : | 62.8  |
| RSI | RSI(14): 63 |
|||
| 52-week | High : | 1.07 | Low : | 0.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RVP ] has closed below upper band by 19.9%. Bollinger Bands are 146.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.99 - 1 | 1 - 1 |
| Low: | 0.9 - 0.9 | 0.9 - 0.91 |
| Close: | 0.97 - 0.98 | 0.98 - 0.99 |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Wed, 15 Oct 2025
Shaw Thomas J, president and CEO, buys Retractable Technologies Inc (RVP) stock worth $13,147 - Investing.com Canada
Thu, 09 Oct 2025
Shaw, Retractable Technologies CEO, buys $27,699 in stock - Investing.com
Tue, 30 Sep 2025
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - MarketScreener
Thu, 25 Sep 2025
Shaw, president and CEO of Retractable, buys $14k in RVP stock - Investing.com
Thu, 21 Aug 2025
Retractable Technologies Stock Gains Following Q2 Earnings Growth - Nasdaq
Tue, 19 Aug 2025
Shaw, president of Retractable Technologies, buys $26k in RVP - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 30 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 56.8 (%) |
| Held by Institutions | 7.5 (%) |
| Shares Short | 38 (K) |
| Shares Short P.Month | 35 (K) |
| EPS | -0.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.84 |
| Profit Margin | -46.8 % |
| Operating Margin | -95.6 % |
| Return on Assets (ttm) | -4.5 % |
| Return on Equity (ttm) | -19 % |
| Qtrly Rev. Growth | -24.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.27 |
| EBITDA (p.s.) | -0.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | -1.63 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0.76 |
| Price to Cash Flow | 5.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|